Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiqin Luo

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Biology Reports|December 1, 2025
Glutamine reprogramming affects the tumor microenvironment and immune response in hepatocellular carcinomaYong Sun, Yi Cui, Daiqin Luo, et al.
Journal of Cellular and Molecular Medicine|December 23, 2023
Pirfenidone inhibits TGF-β1-induced metabolic reprogramming during epithelial-mesenchymal transition in non-small cell lung cancerShuling Zhang, Yuanmei Wang, Daiqin Luo, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 24, 2021
MPEG-PCL Nanomicelles Platform for Synergistic Metformin and Chrysin Delivery to Breast Cancer in MiceDaiqin Luo, Xinjun Wang, Xiaomei Zhong, et al.
Frontiers in Immunology|March 6, 2026
Albumin-bound paclitaxel drives a cytotoxic CD8<sup>+</sup> T cell enriched immune microenvironment in triple negative breast cancerDaiqin Luo, Xianhuai Jin, Shuai Zhang, et al.
Journal of Cellular and Molecular Medicine|January 18, 2023
Pirfenidone suppressed triple-negative breast cancer metastasis by inhibiting the activity of the TGF-β/SMAD pathwayDaiqin Luo, Xianlin Zeng, Shuling Zhang, et al.
Plos One|September 4, 2024
High-dose radiation-induced immunogenic cell death of bladder cancer cells leads to dendritic cell activationXianlin Zeng, Daiqin Luo, Shuai Zhang, et al.
Frontiers in Oncology|April 23, 2025
Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancerYongxia Li, Yong Li, Taolang Li, et al.
Medicine|December 27, 2019
Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancerFenghu Li, Bi Wang, Mingyuan He, et al.
BMC Urology|May 24, 2022
Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathwayZhiyong Shen, Dong Xue, Kun Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Biology Reports|December 1, 2025
Glutamine reprogramming affects the tumor microenvironment and immune response in hepatocellular carcinomaYong Sun, Yi Cui, Daiqin Luo, et al.
Journal of Cellular and Molecular Medicine|December 23, 2023
Pirfenidone inhibits TGF-β1-induced metabolic reprogramming during epithelial-mesenchymal transition in non-small cell lung cancerShuling Zhang, Yuanmei Wang, Daiqin Luo, et al.
Anti-Cancer Agents in Medicinal Chemistry|June 24, 2021
MPEG-PCL Nanomicelles Platform for Synergistic Metformin and Chrysin Delivery to Breast Cancer in MiceDaiqin Luo, Xinjun Wang, Xiaomei Zhong, et al.
Frontiers in Immunology|March 6, 2026
Albumin-bound paclitaxel drives a cytotoxic CD8<sup>+</sup> T cell enriched immune microenvironment in triple negative breast cancerDaiqin Luo, Xianhuai Jin, Shuai Zhang, et al.
Journal of Cellular and Molecular Medicine|January 18, 2023
Pirfenidone suppressed triple-negative breast cancer metastasis by inhibiting the activity of the TGF-β/SMAD pathwayDaiqin Luo, Xianlin Zeng, Shuling Zhang, et al.
Plos One|September 4, 2024
High-dose radiation-induced immunogenic cell death of bladder cancer cells leads to dendritic cell activationXianlin Zeng, Daiqin Luo, Shuai Zhang, et al.
Frontiers in Oncology|April 23, 2025
Efficacy and safety of pyrotinib in the treatment of HER2-positive liver metastatic advanced breast cancerYongxia Li, Yong Li, Taolang Li, et al.
Medicine|December 27, 2019
Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancerFenghu Li, Bi Wang, Mingyuan He, et al.
BMC Urology|May 24, 2022
Metformin exerts an antitumor effect by inhibiting bladder cancer cell migration and growth, and promoting apoptosis through the PI3K/AKT/mTOR pathwayZhiyong Shen, Dong Xue, Kun Wang, et al.
Pageof 1